Viridian Therapeutics, Inc.DE Cash And Cash Equivalents At Carrying Value

Quick Answer

Viridian Therapeutics, Inc.DE reported Cash And Cash Equivalents At Carrying Value of $32.61 million for the year ending 2018.

  • Viridian Therapeutics, Inc.DE showed a decrease of -31.3% in Cash And Cash Equivalents At Carrying Value from 2017 to 2018.
  • This data is from Viridian Therapeutics, Inc.DE's annual report (Form 10-K), filed with the SEC on March 14, 2019.
  • XBRL data for this metric is available from 2013 to 2018 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2013 to 2018), Viridian Therapeutics, Inc.DE's Cash And Cash Equivalents At Carrying Value has grown by 15,501.0%.
  • Historical annual values: Fiscal year 2018: $32.61 million | Fiscal year 2017: $47.44 million | Fiscal year 2016: $22.10 million | Fiscal year 2015: $21.24 million | Fiscal year 2014: $5.12 million | Fiscal year 2013: $209.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: